Last Updated: September 24, 2026

CARDIOPLEGIC IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cardioplegic In Plastic Container patents expire, and what generic alternatives are available?

Cardioplegic In Plastic Container is a drug marketed by Baxter Hlthcare and Fresenius Kabi Usa and is included in two NDAs.

The generic ingredient in CARDIOPLEGIC IN PLASTIC CONTAINER is calcium chloride; magnesium chloride; potassium chloride; sodium chloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CARDIOPLEGIC IN PLASTIC CONTAINER?
  • What are the global sales for CARDIOPLEGIC IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for CARDIOPLEGIC IN PLASTIC CONTAINER?
Summary for CARDIOPLEGIC IN PLASTIC CONTAINER
Recent Clinical Trials for CARDIOPLEGIC IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sakarya UniversityNA
Fayoum University HospitalPHASE4
Universit Vita-Salute San RaffaelePHASE4

See all CARDIOPLEGIC IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for CARDIOPLEGIC IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CARDIOPLEGIC IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium chloride SOLUTION;PERFUSION, CARDIAC 075323-001 Apr 21, 2000 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa CARDIOPLEGIC IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium chloride SOLUTION;PERFUSION, CARDIAC 214623-001 Feb 18, 2022 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.